FSTL3 and colorectal carcinoma: In addition, the data from other databases, including the Human Protein Atlas project3, OncoLnc4, GSE17536 and GSE41258, further displayed that abundant FSTL3 expression was a poor prognostic factor in CRC patients (Supplementary Figure 2).